Cargando…

Editorial: Metabolism in nonalcoholic fatty liver disease

Detalles Bibliográficos
Autores principales:	Najjar, Sonia Michael, Ghadieh, Hilda Elias, Sekar, Revathi, Carraro, Raffaele, Noriega, Lilia G., Paes, Antonio Marcus de Andrade
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478236/ https://www.ncbi.nlm.nih.gov/pubmed/37675278 http://dx.doi.org/10.3389/fphys.2023.1275319

Ejemplares similares

Role of Insulin Clearance in Insulin Action and Metabolic Diseases
por: Ghadieh, Hilda E., et al.
Publicado: (2023)

Editorial: The role of dietary fatty acids in metabolic health
por: Bordoni, Laura, et al.
Publicado: (2023)

Loss of Hepatic Carcinoembryonic Antigen‐Related Cell Adhesion Molecule 1 Links Nonalcoholic Steatohepatitis to Atherosclerosis
por: Ghadieh, Hilda E., et al.
Publicado: (2020)

SUN-079 Loss of Endothelial CEACAM1 Induces Atherogenic Fibrous Plaque Formation
por: Abu Helal, Raghd, et al.
Publicado: (2019)

Regulation of Insulin Clearance by Non-Esterified Fatty Acids
por: Najjar, Sonia M., et al.
Publicado: (2022)

Effect of Exercise Training on Serum Transaminases in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Hong, Feng, et al.
Publicado: (2022)

Synergistic delivery of resveratrol and ultrasmall copper-based nanoparticles by aptamer-functionalized ultrasound nanobubbles for the treatment of nonalcoholic fatty liver disease
por: Guo, Xinmin, et al.
Publicado: (2022)

Lipoprotein metabolism in nonalcoholic fatty liver disease
por: Jiang, Zhenghui Gordon, et al.
Publicado: (2013)

Metabolic Targets in Nonalcoholic Fatty Liver Disease
por: Esler, William P., et al.
Publicado: (2019)

Macrophage metabolism in nonalcoholic fatty liver disease
por: Zhang, Wenhui, et al.
Publicado: (2023)

Loss of Hepatic CEACAM1: A Unifying Mechanism Linking Insulin Resistance to Obesity and Non-Alcoholic Fatty Liver Disease
por: Heinrich, Garrett, et al.
Publicado: (2017)

SAT-151 Hyperinsulinemia-Driven Progressive Metabolic Dysfunction in Male Mice with Liver-Specific CEACAM1 Deletion
por: Ghadieh, Hilda, et al.
Publicado: (2019)

Circadian Clock Genes in the Metabolism of Non-alcoholic Fatty Liver Disease
por: Shi, Dongmei, et al.
Publicado: (2019)

Extracellular Vesicles in Pathogenesis and Treatment of Metabolic Associated Fatty Liver Disease
por: Sun, Ji, et al.
Publicado: (2022)

Gut Microbial Metabolism and Nonalcoholic Fatty Liver Disease
por: Sharpton, Suzanne R., et al.
Publicado: (2018)

An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease
por: Pei, Ke, et al.
Publicado: (2020)

Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
por: Gu, Weijun, et al.
Publicado: (2022)

Editorial: Liver Myofibroblasts
por: Kanta, Jiri, et al.
Publicado: (2016)

Metabolic Profiling Analysis of Liver in Landes Geese During the Formation of Fatty Liver via GC-TOF/MS
por: Yu, Yuzhu, et al.
Publicado: (2022)

Editorial: Cell-to-cell communications in alcohol-associated, metabolic-related and viral liver diseases
por: Osna, Natalia A., et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

The Influence of Metabolic Factors for Nonalcoholic Fatty Liver Disease in Women
por: Chung, Goh Eun, et al.
Publicado: (2015)

Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD)
por: Zarghamravanbakhsh, Paria, et al.
Publicado: (2021)

Frailty in metabolic syndrome, focusing on nonalcoholic fatty liver disease
por: Karakousis, Nikolaos D., et al.
Publicado: (2022)

Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease
por: Bhat, Neha, et al.
Publicado: (2023)

Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice
por: Niu, Shu, et al.
Publicado: (2023)

Identification of metabolic biomarkers associated with nonalcoholic fatty liver disease
por: Jiang, Hua, et al.
Publicado: (2023)

Editorial: Women in lipid and fatty acid research: 2022
por: Cifarelli, Vincenza, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease in adolescents with phenylketonuria
por: Silveira, Adriana Márcia, et al.
Publicado: (2022)

Chlorogenic acid/chromium supplement rescues diet-induced insulin resistance and obesity in mice
por: Ghadieh, Hilda E, et al.
Publicado: (2015)

Referral Patterns for Patients with Nonalcoholic Fatty Liver Disease
por: Rashu, Elias Badal, et al.
Publicado: (2021)

Editorial: Free Fatty Acids as Signaling Molecules: Role of Free Fatty Acid Receptors and CD36
por: Puebla, Carlos, et al.
Publicado: (2022)

Ameliorative effects of black ginseng on nonalcoholic fatty liver disease in free fatty acid–induced HepG2 cells and high-fat/high-fructose diet-fed mice
por: Park, Miey, et al.
Publicado: (2020)

Editorial: Metabolism and Vascular Diseases
por: Zhi, Kangkang, et al.
Publicado: (2022)

Editorial: Lipid metabolism in obesity
por: Giudetti, Anna Maria
Publicado: (2023)

Intestinal Microbiota Modulation in Obesity-Related Non-alcoholic Fatty Liver Disease
por: Porras, David, et al.
Publicado: (2018)

From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
por: Kang, Seong Hee, et al.
Publicado: (2021)

Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
por: Alam, Shahinul, et al.
Publicado: (2021)

SAT-174 Loss of CEACAM1 in Endothelial Cells Causes Hepatic Fibrogenesis
por: Muturi, Harrison, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_809tfhnne5q5ng0ls8tgla3vph